GKOS
Glaukos Corp
NYSE: GKOS · HEALTHCARE · MEDICAL DEVICES
$116.96
-2.23% today
Updated 2026-04-29
Market cap
$7.00B
P/E ratio
—
P/S ratio
13.80x
EPS (TTM)
$-3.28
Dividend yield
—
52W range
$73 – $130
Volume
0.7M
Glaukos Corp (GKOS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-37.00%
Operating margin
-18.90%
ROE
-26.40%
ROA
-5.80%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | $2.43M | $-19.33M | 31.86% | -909.76% | -795.84% |
| 2013 | $20.95M | $-12.64M | 87.90% | -67.78% | -60.34% |
| 2014 | $45.59M | $-12.13M | 74.95% | -28.89% | -26.60% |
| 2015 | $71.70M | $-37.24M | 81.89% | -14.36% | -51.94% |
| 2016 | $114.40M | $4.52M | 85.86% | 3.71% | 3.95% |
| 2017 | $159.25M | $-92000.00 | 86.78% | -1.43% | -0.06% |
| 2018 | $181.28M | $-12.95M | 86.17% | -7.17% | -7.14% |
| 2019 | $236.98M | $15.42M | 83.72% | -21.22% | 6.51% |
| 2020 | $224.96M | $-120.35M | 59.23% | -54.92% | -53.50% |
| 2021 | $294.01M | $-49.59M | 77.34% | -11.18% | -16.87% |
| 2022 | $282.86M | $-99.19M | 75.61% | -29.10% | -35.07% |
| 2023 | $314.71M | $-134.66M | 75.99% | -40.89% | -42.79% |
| 2024 | $383.48M | $-146.37M | 75.48% | -31.91% | -38.17% |
| 2025 | $507.44M | $-187.69M | 55.72% | -39.33% | -36.99% |